FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: opalapril who wrote (43)	2/7/2000 11:52:00 AM
From: aknahow	Read Replies (1) of 75

This tread continues to pose a contradiction. The risk are that even promising P III drugs end up not approved. For years it has been demonstrated that one can reduce risk by purchasing a bioteck only after approval. Why not limit discussion to companies that have just received approval? Do not do so leads to the thread being used by some to promote companies under the mantel of them somehow fitting into the low risk catagory described in the original post. There is a company, I will mention as super low risk, once it has obtained approval, if it ever does. Until such time I would feel that mentioning it here would be inappropriate, even though recent events have made it 1/10 as risky as it was before. Without approval it still is risky, before it was very risky.<g>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next